Pharmaceuticals

GSK accused of paying off rivals to delay entry of generic drugs

19 Apr 2013

The UK regulator today said that GSK has made substantial payments to three smaller rivals to stop them from releasing generic versions of its paroxetine anti-depressant drug Seroxat

Orchid Chemicals inks antibiotics development pact with Europe’s Allecra Therapeutics

18 Apr 2013

Cipla launches first biosimilar drug for rheumatic disorders

17 Apr 2013

Thermo Fisher nears $12.8-bn takeover of Life Technologies: report

15 Apr 2013

A successful deal would be the biggest acquisition for Thermo Fisher, the world's second-largest maker of lab instruments, since the 2006 merger of Thermo Electron and Fisher Scientific International for $12.8 billion

Shareholders of Irish drug maker Elan approve $1 bn buyback

13 Apr 2013

Eli Lilly to lay off around 1,000 sales personnel in US

12 Apr 2013

India-EU free-trade pact may undermine WTO’s patent agreement

10 Apr 2013

The civil society is opposing the intellectual property related issues in the proposed FTA that would impact access to affordable medicines across the developing world

GVK BIO licences out its SAR database to Scottish drug discovery body

10 Apr 2013

Germany's Merz Pharma withdraws bid for Obagi Medical Products

08 Apr 2013

AstraZeneca’s rheumatoid arthritis pill fostamatinib shows mixed results in trial

08 Apr 2013

Drug firms paid UK doctors £40 million for travel and expenses: Pharma industry body

06 Apr 2013

Delhi HC refuses interim relief to Merck over Glenmark drug

05 Apr 2013

Glenmark said the US drug firm has no patent rights over ‘Sitagliptin Phosphate’, which is used in its anti-diabetes drugs Zita and Zita-Met

Astellas in oncology antibody drug pact with Ambrx

05 Apr 2013

Valeant Pharma outbids Merz for control of Obagi Medical Products

04 Apr 2013

Pfizer, Novartis, Abbott in race for Brazil’s Ache Laboratorios: report

03 Apr 2013

SC ruling on Novartis patent disappoints US Inc; but NGOs cheer

03 Apr 2013

Novartis loses patent battle in SC over cancer drug Glivec

01 Apr 2013

The Supreme Court on Monday dismissed Swiss drug multinational Novartis AG's attempt to win patent protection for its cancer drug Glivec, ending a seven-year battle over the issue

Novartis AG will cut stake in Indian arm to meet SEBI norms

28 Mar 2013

Novartis expects ‘negative’ SC verdict in Glivec patent case

28 Mar 2013

AstraZeneca settles Crestor lawsuit with Egis and Actavis

25 Mar 2013

S Africa’s Bidvest to raise stake in drugmaker Adcock Ingram to 60%

23 Mar 2013

Valeant Pharmaceuticals to acquire Obagi Medical Products for $344 mn

21 Mar 2013

AstraZeneca to eliminate 1,600 jobs in major R&D restructuring

19 Mar 2013

Pascal Soriot, CEO  says the overhaul would lead to $1.4 billion in one-time restructuring charges, with annualised benefits expected to reach approximately $190 million by 2016

First Chinese pharma firm fined for price fixing in the US

18 Mar 2013

US cosmetic laser manufacturer Cynosure to buy rival Palomar Medical

18 Mar 2013